Institution identification

PURI

https://redirect.ema.europa.eu/resource/39920

Institution ID

39920

Institution full name and acronym

Syneos Health

Institution countries

United Kingdom

Type of institution

Non-Pharmaceutical company

Institution website

ENCePP partner

Yes
Institution description
Syneos Health is a global Contract Research Organisation (CRO) and Contract Commercial Organisation (CCO),purpose-built to offer comprehensive solutions spanning from concept to commercialisation. We are therapeutically focused and have a dedicated team that specialises in peri-approval, post-approval, epidemiological and health economics and outcomes research. With our scientific and operational expertise we assist with all stages of late phase research, including designing and executing post-authorization studies, disease and pregnancy registries and multinational chart/electronic medical records review studies. We also offer consulting services for evidence planning.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact

Studies conducted by the institution

A 24-Month Prospective Observational Cohort Study Evaluating Oral Systemic Therapies in the Management of Adult Patients with Atopic Dermatitis in REAL-World Practice (AD-REAL)
A Long-Term, Prospective, Observational Study to Evaluate the Safety, Including Cardiovascular Safety, of Fremanezumab in Patients with Migraine in Routine Clinical Practice Non-Interventional Phase 4 Study
A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease‑Modifying Therapies (RA-BE-REAL)
A Prospective Observational Safety Study on Pregnancy Outcomes in Women Immunized With Seasonal Cell Culture Influenza Trivalent (TIVc) or Quadrivalent (QIVc) Vaccine During Pregnancy (Flucelvax (TIVc or QIVc) Pregnancy Registry)
A prospective, registry based, observational study to asses maternal, fetal and infant outcomes following exposure to lasmiditan
A Retrospective Chart Review Study to Evaluate Safety of McGhan Single Lumen Gel-Filled Breast Implants in Patients in China
An International Pregnancy Exposure registry of Women With Multiple Sclerosis (MS) exposed to Teriflunomide (OBS12751)
An International, Multicenter, Prospective Non-Interventional Study of Real-World Treatment Outcomes in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC) treated with Talazoparib and Enzalutamide (TALENZA)
Assessment of pregnancy outcomes in patients treated with Ajovy (fremanezumab): pregnancy registry (Teva migraine pregnancy registry)
Evaluation of the Safety and Effectiveness of BOTOX® (Botulinum Toxin Type A) in the Treatment of Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity or Overactive Bladder: A Phase IV Non-interventional Post-marketing Surveillance Study in India
Observational Study Description H6D-MC-LVHQ(b) A Prospective Case-Crossover Study to Evaluate the Possible Association Between the Use of PDE5 inhibitors and the Risk of Acute Nonarteritic Anterior Ischaemic Optic Neuropathy (NAION)
Post-Authorization Safety Study to Assess the Effectiveness of the Newly Implemented Risk Minimization Measures for Topiramate: Drug Utilization Study
Prospective pregnancy study to assess maternal and fetal outcomes following exposure to galcanezumab (I5Q-MC-B005)
Psoriatic Arthritis Observational Study of Persistence of Treatment (PRO-SPIRIT Study)
THE SAVELLA® PREGNANCY REGISTRY (MLN-MD-30 / CMO-EPI-NEU-0539)